About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

High Flow Nasal Cannula (HFNC) Initiation Flow Rate Study

NCT04517344·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Texas Southwestern Medical Center

Age

0–1

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients less than 12 months of age
Clinical signs of moderate to severe bronchiolitis defined by American Academy of Pediatrics
Requires ICU level of care by clinicians' discretion
Requiring HFNC support

You may not be if

Infants who required immediate need for respiratory support such as non-invasive positive pressure ventilation (NIPPV) or invasive ventilation
Congenital heart disease,
Immunocompromised state
Upper airway obstruction
Chronic lung disease
Bronchopulmonary dysplasia,
Home oxygen therapy requirement
Acute trauma patients
Baseline craniofacial malformations
Admitted to the neonatal or cardiac ICUs
Patients who are admitted to the floor

The record

StatusTerminated

PhaseNo phase

Taking part21

StartedDec 2020

UpdatedMay 16, 2025

Conditions

Where1

Children's Health - Children's Medical Center
Dallas, Texas, United States

Clareo Health | High Flow Nasal Cannula (HFNC) Initiation Flow Rate Study